HAEMOLYTIC URAEMIC SYNDROME

This adverse event was reported 2320 times

These drugs are most commonly taken by patients reporting HAEMOLYTIC URAEMIC SYNDROME:

# Drug Count
0 TACROLIMUS 346
1 TACROLIMUS EXTENDED-RELEASE CAPSULES 284
2 TACROLIMUS OINTMENT 0.1% 284
3 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 250
4 MYCOPHENOLATE MOFETIL 249
5 GEMCITABINE HYDROCHLORIDE 239
6 ECULIZUMAB 202
7 GEMCITABINE 185
8 PREDNISONE 174
9 PREDNISOLONE 150
See all common drugs associated with HAEMOLYTIC URAEMIC SYNDROME

HAEMOLYTIC URAEMIC SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MITOMYCIN 24 0.0066
1 BELATACEPT 29 0.0061
2 BASILIXIMAB 69 0.0058
3 ANTI-THYMOCYTE GLOBULIN (RABBIT) 45 0.0055
4 GEMCITABINE HYDROCHLORIDE 239 0.0044
5 CEFOTAXIME INJECTION 18 0.0041
6 ECULIZUMAB 202 0.0037
7 VANCOMYCIN HYDROCHLORIDE 31 0.0037
8 NEPAFENAC 11 0.0034
9 CARFILZOMIB 96 0.0034
See all drugs enriched for association with HAEMOLYTIC URAEMIC SYNDROME